Clinical Trial - Novel Treatment of Suicidality

Accessibility links

Clinical Trial - Novel Treatment of Suicidality

Breadcrumbs

Suicide is identified as a leading public health issue in Australia and has a devastating effect on families and health providers.

The Suicide Prevention research team is seeking individuals who experience chronic suicidality to participate in a clinical trial investigating the efficacy of a novel drug treatment.

Eligibility criteria: 

  1. Over 18 years of age.
  2. Experience chronic suicidal thoughts.
  3. Do not require urgent psychiatric intervention for their suicidality.
  4. Do not have cardiovascular disease.

Bellberry Limited approval: 2017-12-982. USC HREC: A181101

Register your interest

If you are interested in being involved in our study please complete the below form.

Back to top

Pro tip: To search, just start typing - at any time, on any page.

Searching {{ model.SearchType }} for returned more than {{ model.MaxResults }} results.
The top {{ model.MaxResults }} of {{ model.TotalItems }} are shown below.

Searching {{ model.SearchType }} for returned {{ model.TotalItems }} results.

Searching {{ model.SearchType }} for returned no results.